Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Moodys
Baxter
Dow
Boehringer Ingelheim

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Interferon alfa-2b - Biologic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Recent Clinical Trials for interferon alfa-2b

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Allergy- and pulmonary Clinic, Vanloese.Phase 4
Bispebjerg HospitalPhase 4
Lund UniversityPhase 4

See all interferon alfa-2b clinical trials

Recent Litigation for interferon alfa-2b

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Bay State Milling Company v. Arcadia Biosciences, Inc.2019-04-01
Boston Heart Diagnostics Corporation v. MD Labs, Inc.2018-01-05
Boston Heart Diagnostics Corporation v. Genelex Corporation2017-08-01

See all interferon alfa-2b litigation

PTAB Litigation
PetitionerDate
Regeneron Pharmaceuticals, Inc.2019-09-20
Baylor College of Medicine2018-04-18
Guardant Health, Inc.2017-05-17

See all interferon alfa-2b litigation

Pharmacology for interferon alfa-2b

Company Disclosures: US Patents for interferon alfa-2b

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Biogen N.V. (Curacao, AN) 2002-07-23 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2039-03-29 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Schering Corporation (Kenilworth, NJ) 2014-10-11 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Hoffman-La Roche Inc. (Nutley, NJ) Genentech, Inc. (South San Francisco, CA) 2020-08-26 RX company
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Schering Corporation (Madison, NJ) 2002-11-19 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for interferon alfa-2b

These patents were identified by searching patent claims

Supplementary Protection Certificates for interferon alfa-2b

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017 00055 Denmark   Start Trial PRODUCT NAME: NUSINERSEN ELLER SALTE DERAF; REG. NO/DATE: EU/1/17/1188 20170601
2017 00055 Denmark   Start Trial PRODUCT NAME: NUSINERSEN ELLER SALTE DERAF; REG. NO/DATE: EU/1/17/1188 20170601
C/GB03/011 United Kingdom   Start Trial SPC/GB03/011:, EXPIRES: 20071203
0466199/03 Switzerland   Start Trial PRODUCT NAME: OCTOCOG ALFA CHO; REGISTRATION NUMBER/DATE: IKS 53627 21.12.1995
0905 Netherlands   Start Trial PRODUCT NAME: NUSINERSEN, DESGEWENST IN DE VORM VAN EEN ZOUT; REGISTRATION NO/DATE: EU/1/17/1188 20170601
C/GB03/012 United Kingdom   Start Trial PRODUCT NAME: OCOTOCOG ALFA AS PRESENT IN THE APPROVED PRODUCT KOGENATE, IN ALL FORMS SUBJECT TO THE BASIC PATENT; REGISTERED: NL RVG 16790 19940415; NL RVG 16791 19940415; NL RVG 16789 19940415; UK PL/0010/0194 19940517; UK PL/0010/0195 19940517; UK PL/0010/0196 19940517
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Johnson and Johnson
Baxter
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.